These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7489960)

  • 1. Disseminated intravascular coagulation in endemic hepatosplenic schistosomiasis.
    Omran SA; el-Bassiouni NE; Hussein NA; Akl MM; Hussein AT; Mohamed AA
    Haemostasis; 1995; 25(5):218-28. PubMed ID: 7489960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of factors II, VII, IX, X, and protein C in hepatosplenic schistosomiasis.
    Amin HM; Omran SA; el-Bassuoni NE; el-Kaliouby AH; el-Ashmawy SA
    Haemostasis; 1994; 24(1):22-6. PubMed ID: 7959352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibronectin, platelet factor 4 and beta-thromboglobulin in endemic hepatosplenic schistosomiasis: relation to acute hematemesis.
    el-Bassiouni NE; el Bassiouny AE; Akl MM; el-Khayat HR
    Haemostasis; 1997; 27(1):39-48. PubMed ID: 9097085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinopeptide A in liver cirrhosis: evidence against a major contribution of disseminated intravascular coagulation to coagulopathy of chronic liver disease.
    Mombelli G; Fiori G; Monotti R; Haeberli A; Straub PW
    J Lab Clin Med; 1993 Jan; 121(1):83-90. PubMed ID: 8426084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High D-dimer levels: a possible index of risk of overt disseminated intravascular coagulation and/or digestive bleeding in advanced liver cirrhosis?
    Cioni G; Cristani A; Vignoli A; Ventura E
    Recenti Prog Med; 1994 Apr; 85(4):230-4. PubMed ID: 8016448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemostatic abnormalities in hepatosplenic schistosomiasis mansoni.
    Tanabe M
    Parasitol Int; 2003 Dec; 52(4):351-9. PubMed ID: 14665393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of hemostatic molecular markers during disseminated intravascular coagulation in patients with liver cirrhosis treated by endoscopic embolization for esophageal varices.
    Koyama T; Kakishita E; Nakai Y; Okamoto E
    Am J Hematol; 1991 Oct; 38(2):90-4. PubMed ID: 1719808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The coagulation profile in hepatosplenic schistosomiasis.
    El-Bassiouni NE; El Bassiouny AE; Hussein NA; El-Sayed HH; Ibrahim IM; Lotfy MG; Omran SA
    Blood Coagul Fibrinolysis; 1998 Mar; 9(2):189-94. PubMed ID: 9622218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pathogenesis of accelerated fibrinolysis in hepatosplenic schistosomiasis.
    Omran SA; Madkour BA; Essawy FM; Toima SM; el Kaliouby AH; Shams el Din AA
    Blood Coagul Fibrinolysis; 1992 Dec; 3(6):819-22. PubMed ID: 1489902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemostatic dysfunction is increased in patients with hepatosplenic schistosomiasis mansoni and advanced periportal fibrosis.
    Leite LA; Pimenta Filho AA; Martins da Fonseca CS; Santana dos Santos B; Ferreira Rde C; Montenegro SM; Lopes EP; Domingues AL; Owen JS; Lima VL
    PLoS Negl Trop Dis; 2013; 7(7):e2314. PubMed ID: 23875049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disseminated intravascular coagulation in liver cirrhosis: fact or fiction?
    Ben-Ari Z; Osman E; Hutton RA; Burroughs AK
    Am J Gastroenterol; 1999 Oct; 94(10):2977-82. PubMed ID: 10520855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Problems of diagnosis of disseminated intravascular coagulation (DIC).
    Bowie EJ; Owen CA
    Southeast Asian J Trop Med Public Health; 1979 Sep; 10(3):325-7. PubMed ID: 515796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperfibrinolysis in hepatosplenic schistosomiasis.
    el-Bassiouni NE; el Bassiouny AE; el-Khayat HR; Akl MM; Omran SA
    J Clin Pathol; 1996 Dec; 49(12):990-3. PubMed ID: 9038736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of contact activation in endemic hepatosplenomegaly.
    Omran SA; Amer AM; el-Kaliouby AH; Eldin AA
    Blood Coagul Fibrinolysis; 1991 Oct; 2(5):659-62. PubMed ID: 1782336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disseminated intravascular coagulation: the application and utility of diagnostic tests.
    Ockelford PA; Carter CJ
    Semin Thromb Hemost; 1982 Jul; 8(3):198-216. PubMed ID: 6215711
    [No Abstract]   [Full Text] [Related]  

  • 16. Higher prognostic value of soluble fibrin complexes than D-dimer and fibrin degradation product for disseminated intravascular coagulation in patients with liver cirrhosis.
    Kim SY; Kim JE; Kim HK; Kim I; Yoon SS; Park S
    Blood Coagul Fibrinolysis; 2013 Mar; 24(2):150-6. PubMed ID: 23314386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin K dependent coagulation proteins in endemic hepatosplenomegaly in Egypt.
    Omran SA; Amin HM; el-Bassiouni NE; Essawy FM; Toiema SM
    J Clin Pathol; 1994 Jun; 47(6):502-4. PubMed ID: 8063929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do coagulation screening tests detect increased generation of thrombin and plasmin in sick newborn infants?
    Schmidt B; Vegh P; Johnston M; Andrew M; Weitz J
    Thromb Haemost; 1993 May; 69(5):418-21. PubMed ID: 8322263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Coagulation disorders in patients with liver cirrhosis].
    Ihle E; Schimmelpfennig W
    Z Arztl Fortbild (Jena); 1983; 77(22):929-34. PubMed ID: 6659589
    [No Abstract]   [Full Text] [Related]  

  • 20. [Evaluation of several parameters of coagulation in liver cirrhosis: disseminated intravascular coagulation or pseudo-disseminated intravascular coagulation?].
    Petrella V; Parachini F; Rigotti T; Galimberti M; Cusumano S
    Minerva Med; 1988 Mar; 79(3):193-8. PubMed ID: 3362400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.